[HTML][HTML] Omicron variant: Current insights and future directions

R Rana, R Kant, RS Huirem, D Bohra… - Microbiological …, 2022 - Elsevier
The global COVID-19 outbreak has returned with the identification of the SARS-CoV-2
Omicron variant (B. 1.1. 529) after appearing to be persistently spreading for the more than …

Choosing a cellular model to study SARS-CoV-2

GA Pires De Souza, M Le Bideau, C Boschi… - Frontiers in cellular …, 2022 - frontiersin.org
As new pathogens emerge, new challenges must be faced. This is no different in infectious
disease research, where identifying the best tools available in laboratories to conduct an …

COVID-19 annual update: a narrative review

M Biancolella, VL Colona, L Luzzatto, JL Watt… - Human genomics, 2023 - Springer
Three and a half years after the pandemic outbreak, now that WHO has formally declared
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …

Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis

Z Li, S Liu, F Li, Y Li, Y Li, P Peng, S Li, L He… - Frontiers in …, 2022 - frontiersin.org
Background Older adults are more susceptible to severe health outcomes for coronavirus
disease 2019 (COVID-19). Universal vaccination has become a trend, but there are still …

Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2

M Giovanetti, F Branda, E Cella… - Journal of Medical …, 2023 - Wiley Online Library
This comprehensive review focuses on the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) and its impact as the cause of the COVID‐19 pandemic. Its objective is to …

Effectiveness of international border control measures during the COVID-19 pandemic: a narrative synthesis of published systematic reviews

KA Grépin, J Aston, J Burns - … Transactions of the …, 2023 - royalsocietypublishing.org
The effectiveness of international border control measures during the COVID-19 pandemic
is not well understood. Using a narrative synthesis approach to published systematic …

Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants

J Cho, Y Shin, JS Yang, JW Kim, KC Kim, JY Lee - Antiviral research, 2023 - Elsevier
Ongoing emergence of SARS-CoV-2 Omicron subvariants and their rapid worldwide spread
pose a threat to public health. From November 2022 to February 2023, newly emerged …

Severity of COVID-19 among hospitalized patients: Omicron remains a severe threat for immunocompromised hosts

L Nevejan, S Ombelet, L Laenen, E Keyaerts… - Viruses, 2022 - mdpi.com
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged in the general population in the context of a relatively high immunity gained …

Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and omicron …

J Chansaenroj, N Suntronwong, S Kanokudom… - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively
evaluated globally due to waning immunity and the emergence of new severe acute …

Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and …

A Kandeel, Y Moatasim, M Fahim, H Bahaaeldin… - BMC Infectious …, 2023 - Springer
Background The o severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic has
killed millions of people and caused widespread concern around the world. Multiple genetic …